SPC519
Seladelpar eða lyfjafræðilega viðunandi salt þar af, sérstaklega seladelpar L-lýsíndíhýdrat / Seladelpar or a pharmaceutically acceptable salt thereof, in particular seladelpar L-lysine dihydrate
Status:
UmsóknApplication date:
5.8.2025Application published:
1.9.2025
Medicine name:
Seladelpar Gilead (breytt í Lyvdelzi í apríl 2025)Medicine for children:
No
Timeline
Today
5.8.2025Application
1.9.2025Publication
Marketing license
IS authorization number:
EU1/24/1898Date:
28.2.2025
Foreign authorization number:
EU/1/24/1898Date:
20.2.2025
Owner
Name:
CymaBay Therapeutics, Inc.Address:
333 Lakeside Drive, Foster City US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3119384